This article was reviewed by Darragh O’Carroll, MD. Key takeaways: Semaglutide nausea is common: About 20 percent of Ozempic® ...

Researchers found that the odds of developing an eye condition that leads to vision loss were about 5 times higher among ...

As the use of injectable GLP-1 drugs continues to rise, questions persist about what happens after patients stop taking them in real-world settings.

Semaglutide can mitigate antipsychotic-induced metabolic dysfunction in patients with schizophrenia, prediabetes, and overweight or obesity on second-generation antipsychotics.

Mounjaro - the brand name for tirzepatide - has become one of the most talked-about medications in metabolic health, and for good reason. But the conversation around it has gotten tangled up with ...

GLP-1 RAs were first approved for youth with type 2 diabetes with liraglutide (Victoza) in 2019, followed by semaglutide (Wegovy) and dulaglutide (Trulicity) in 2022. Prior to these approvals, insulin ...

As a physician who prescribes GLP-1 medications like Ozempic, Wegovy, semaglutide, and tirzepatide, I explain why increasing ...

How Long It Lasts and Tips to Reduce It This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Nausea is the most ...

The upcoming patent expiry for Ozempic in India is set to dramatically lower the cost of semaglutide, making this once-premium diabetes and weight-loss drug accessible to more patients. This shift ...

From Semaglip, Sematop, Semakind to Semastrike, Semaglyn and Semaril, the pipeline of upcoming Ozempic copycats reads like ...

The reality TV star received a letter from the Food and Drug Administration last month, after they reviewed her GoodGirlRX website.